386 223 captures · dernière capture : 14 avr. 2026
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
243 880 captures · dernière capture : 28 avr. 2026
12 584 captures · dernière capture : 10 avr. 2025
Non-prescription Drug Action Plan On this page About the action plan Policy and operational approach About the action plan Health Canada is committed to simplifying market access for non-prescription drugs. As a first step, we developed the Non-prescription Drug Action Plan. This…
Health Canada: The Food and Consumer Safety Action Plan Your family's safety. Our government's priority. From groceries to prescription drugs and children's toys, you want to know that the food, health and consumer products you use every day are safe. The Government of Canada…
Concerns about children's medication Avoiding cough and cold medications Because of the ingredients they contain, non-prescription cough and cold medicines should never be given to children under the age of six. Always check the label first to make sure the medication is suitable…
Summary Basis of Decision (SBD) Contact: Office of Planning, Performance and Review Services Summary Basis of Decision (SBD) documents explain why Health Canada authorized certain drugs and medical devices for sale in Canada. The documents include regulatory, safety,…
Regulatory Decision Summaries Regulatory Decision Summaries (RDSs) explain Health Canada's decision for certain health products seeking market authorization. The RDSs include the purpose of the submission and the reason for the decision. These pages also include summaries of…
Drug and Health Product Submissions Under Review (SUR): Overview Overview New drug submissions under review Supplemental submissions under review New drug submissions completed Supplemental submissions completed Notice to stakeholders As of March 20, 2026: The lists of…
N/A 2026-01-30 2032-01-30 Yes 2034-07-30 abemaciclib 215268 Verzenio Eli Lilly Canada Inc.
Certificates of Supplementary Protection (CSP) and Applications The Office of Patented Medicines and Liaison (OPML) should be contacted in advance of a CSP application filing deadline in order to obtain a CSP Customer Number or to confirm an existing CSP Customer Number, if it is…
Patent register The Patent Register is an alphabetical listing of medicinal ingredients and their associated patents, the patent expiry dates and other related information established in accordance with the Patented Medicines (Notice of Compliance) Regulations [SOR/133-93 as…
Advisories and Recalls – MedEffect Canada If you are currently suffering from an adverse reaction to drugs or health products, contact your health professional or local health authorities. The Recalls and Safety Alerts Database provides easy access to a comprehensive list of…
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
